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impact of smoking cessation on the progression of throm-
boangiitis obliterans (Buerger’s disease). The impact of
various comorbidities on limb amputation was also
evaluated.
Methods: A retrospective analysis of the cross-
sectional National Inpatient Sample (2000-2011) was
used to identify patients with a diagnosis of Buerger’s
disease (International Classiﬁcation of Diseases, Ninth
Revision, 44.31). Patients who underwent extremity
amputation were characterized according to smoking
status and comorbidities, including renal failure, diabetes,
coagulopathy, hypertension, heart disease, and chronic
obstructive pulmonary disease, and compared with
those who did not undergo amputation. Odds ratios
were calculated for all statistically signiﬁcant (P < .05) dif-
ferences identiﬁed using the Fisher exact test and Student
t-test.
Results: A total of 4,489 patients with Buerger’s
disease were identiﬁed in the United States between
2000 and 2011, of which 193 (4.3%) underwent limb
amputation. A total of 1908 (42.5%) patients were
smokers. Smoking was slightly more common among
patients who underwent amputation (46.1% vs 42.3%;
P ¼ .30; 95% conﬁdence interval, e0.11 to 0.03). Of
the comorbidities evaluated, renal failure was two times
more common among patients who underwent amputa-
tion (6.2% vs 3.2%; OR, 2; P ¼ .02; 95% conﬁdence
interval, e0.06 to e0.004). Patients who were former
smokers were just as likely to require limb amputation
(9.3% vs 11.5%; P ¼ .35).
Conclusions: Although the association between
smoking and Buerger’s disease is well understood,
whether smoking leads to the limb amputation from
this disease is unclear. This study demonstrates that the
primary factor associated with limb amputation
from Buerger’s disease is end-stage renal disease, not
smoking. Further, smoking cessation does not appear to
prevent progression to limb amputation in Buerger’s
disease.
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Vascular Surgeons Can Improve the Cardiovascular
Health of Patients With Clinical Atherosclerotic
Cardiovascular Disease by Implementing an Intensive
Lipid-Lowering Regimen and Providing Smoke
Cessation Counseling
Naren Gupta1, Carla Moreira2, Sarah White1, Summer
Mattera1, Joseph D. Raffetto1, Deepak L. Bhatt3, John
M. Gaziano1, James T. McPhee1. 1VA Boston Health
System, Boston, Mass; 2Boston Medical Center, Boston,
Mass; 3Brigham and Women’s Hospital, Boston, Mass
Objectives: To assess the impact of a vascular surgery-
led program to improve the cardiovascular risk of patients
with clinical atherosclerotic cardiovascular disease
(ASCVD) by implementing an intensive lipid-lowering
regimen and providing smoke cessation counseling.
Methods: The records of all patients seen in a single-
center vascular surgery clinic over a 1-month period inNovember 2013 were retrospectively reviewed till October
1, 2011, when the vascular surgery service implemented a
cardiovascular risk reduction program in patients with clin-
ical ASCVD.
Results: Included were 144 consecutive patients with
a median follow-up of 315 days (range, 0-740 days). Pre-
intervention, the baseline median low-density lipoprotein
(LDL) was 86 mg/dL (range, 39-197 mg/dL) and 96 pa-
tients (71.1%) had an LDL >70 mg/dL. Fifty-two patients
(37%) were current smokers, 41 (71%) smoked heavily
(more than one pack per day). Fifty-ﬁve percent of patients
had documentation that this intervention was administered
at the initial vascular surgery encounter after this program
was started. The mean lag time to the ﬁrst vascular surgery
encounter with intervention documentation was 117 days
(median, 0 days; range 0-721 days). At the latest follow-
up, 92 (72%) of the encounters by a vascular surgeon docu-
mented that the intervention was administered, ﬁnal
median LDL was 79 mg/dL (range, 31-198 mg/dL), 80
patients (62%) had an LDL >70 mg/dL, and 60 patients
(47.2%) had a decrease in their LDL. Patients that had
no observed decrease in their LDL had a signiﬁcantly lower
mean level at baseline (82.3; standard deviation, 28.7;
range 39-197 mg/dL) compared with those with an
observed decrease in LDL (mean, 98.8; standard deviation,
32.8; range, 42-187 mg/dL; P ¼ .003). At the latest
follow-up, 41 patients (31.5%) were currently smoking,
21 (43.7%) of whom smoked heavily (more than one
pack per day).
Conclusions: Vascular surgeons can improve the car-
diovascular health of their patients by implementing a pro-
gram of intensive lipid control and smoking cessation in
patients with clinical ASCVD. Further studies are needed
to determine the impact on cardiovascular event rates.
Author Disclosures: D. L. Bhatt: Nothing to disclose; J.
M. Gaziano: Nothing to disclose; N. Gupta: Nothing to
disclose; S. Mattera: Nothing to disclose; J. T. McPhee:
Nothing to disclose; C. Moreira: Nothing to disclose; J.
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Deﬁning and Reporting Academic Activity: The
Academic RVU Can Justify the Mission
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Alan B. Lumsden, Mark G. Davies. Cardiovascular
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Objectives: The academic mission is under strain.
Although clinical activity is easily quantiﬁed by the Relative
Value Units (RVU), there are multiple ad hoc measures of
academic activity. This study reports the use of academic
RVU (aRVU) derived for all nonclinical activities to justify
nonclinical protected time of individual faculty, prioritize
divisional activities, and drive the academic.
Methods: All nonclinical activity for divisional faculty
were correlated and subjected to a deﬁned scoring sys-
tem. The system was set up in ﬁve modules (publica-
tions, presentation, clinical trial, grants educational,
administration and community). Each module was
Table. Postoperative care in elective EVAR patients:
Mean number of hours treatment was utilized or time
initiated
Indicator (%) Mean Hours Postop
Oxygen 98.5 19
Telemetry 100 12
Arterial catheter 27.3 6
Continuous IV 86.4 12.5
IV ﬂuid bolus 16.7 3.5 (initiated)
IV medication 52.4
Indwelling urinary catheter 67.2 19
Straight catheterization 4.5 14 (initiated)
<3 Laboratory tests 76.2
Diabetic management 37.3
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modulators to describe the strength and weakness of an
activity. Only ongoing productive activities were
measured, and no allowances were made for tenure or
previous achievements.
Results: All activities had effort apportioned to
them. Publications were modulated by type, author po-
sition, and journal impact factor. Presentations were
modulated by level of participation, meeting type and
continuing medical education credit. Grants were
weighted by funding source, annual income, and inves-
tigator classiﬁcation, whereas clinical trials were assesses
by status of recruitment and ﬁnancial reimbursement.
Teaching was based on deﬁned activities, contributions
to the curriculum, and learner scores. When faculty
members were assessed and their budgeted time alloca-
tions compared, all the faculty exceeded their effort re-
quirements. Examples of the system applications to a
clinician, clinician administrator, clinician educator and
clinician researcher will be shown.
Conclusions: Adoption of a universal system of
measuring academic performance is necessary to facilitate fac-
ulty focus and development and allow for a rational budget-
ing of academic time and effort. Production and validation of
the aRVU will allow for constructive and appropriate recog-
nition of activity and contributions to the academic mission.
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G. Davies: Nothing to disclose; H. F. El-sayed: Nothing
to disclose; U. Fischer: Nothing to disclose; A. B.
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disclose; A. Sigdel: Nothing to disclose; M. Unruh:
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Clinical Feasibility and Financial Impact of Same-Day
Discharge in Patients Undergoing Endovascular
Aortic Repair (EVAR) for Elective Infra-Abdominal
Aortic Aneurysm (AAA)
Vincent Moscato, Monica O’Brien-Irr, Maciej Dryjski,
Linda Harris. Department of Surgery, Buffalo General
Medical Center, Buffalo, NY
Objectives: To evaluate the potential feasibility and
ﬁnancial impact of same-day discharge after elective endo-
vascular aneurysm repair (EVAR) for abdominal aortic
aneurysm (AAA).
Methods: All elective EVAR patients from January
2012 to June 2013 were identiﬁed. Demographics,
comorbidities, complications, nursing care, ﬁnancial data,
and length of stay (LOS) were analyzed (SPSS 21).
Results: The Table presents care received in 67 elec-
tive EVAR (70% percutaneous EVAR/61% of AAA). Intra-
operative and postoperative complications were type I
endoleak, 1.5%; thrombosis, 3%; blood loss requiring trans-
fusion, 4.5%; urinary retention, 4.5%; myocardial infarc-
tion, 3%; and hemodynamic/rhythm alterations, 37%
(evident in 24 [88%] <6 hours; 13% required therapy).
Monitoring only was needed in 28 (42%), intensive care
unit in 13.4%. Postoperative day 1 discharge occurred in
73%; 9% <30-day readmission. Total hospital costs:
$29,479: operating room, 80.3%; anesthesia, 2.2%; pread-
mission, 1%; postanesthesia unit, 3.1%; intensive care unit,1.9%; ﬂoor, 4.7%; laboratory/diagnostic tests, 1.2%; phar-
macy, 1.4%; and other, 4.2%. Total cost was similar for
those discharged <24 or >25 hours postoperatively (P ¼
.88) and for monitoring only vs others ($28,146 vs
$30,545; P ¼ .12). Costs for pharmacy ($351 vs $509: P
¼ .05) and laboratory ($86 vs $354: P ¼ .01) and diag-
nostic testing ($3.96 vs $254: P ¼ .02) were lower for un-
complicated cases.
Conclusions: Same-day discharge is clinically feasible
in >40% of elective EVAR, but requires coordination for
adequate postoperative monitoring. Signiﬁcant savings is
unlikely because most cost is operating room- and de-
vice-related, and further reduction of costs in uncompli-
cated cases is unlikely.Author Disclosures: M. Dryjski: Nothing to disclose; L.
Harris: Nothing to disclose; V. Moscato: Nothing to
disclose; M. O’Brien-Irr: Nothing to disclose.PS132.
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Objectives: This study aimed to determine risk factors
associated with perioperative mortality in patients undergo-
ing abdominal aortic aneurysm (AAA) repair nationally and
use these risk factors to create a scoring system and risk reg-
ister to determine mortality rate based on risk scores.
Methods: A retrospective analysis was completed us-
ing the National Inpatient Sample (NIS) from 2000 to
2010. A discriminant analysis was used to predict in-hospi-
tal mortality once predictor variables were identiﬁed using a
multivariate analysis. A risk register was created using
established rates of rupture for various AAA sizes and esti-
mating the average mortality for those patients. This risk
was then compared with the in-hospital mortality risk using
our discriminant analysis to make recommendations on
minimizing overall mortality as a function of aneurysm
size and predictors of mortality.
Results: In the past decade in the United States,
101,978 patients underwent an AAA repair, of which
95,098 survived and 6,780 (7%) died. The following
